News

Arbor, a specialty pharmaceutical company, has announced the launch of Zinotic ES as a new treatment option for Acute Otitis Externa (AOE). Zinotic ES is an extra strength

A registered IRB can extend its federalwide assurance to a trial site, but the assurance doesn’t prove compliance, OHRP director Jerry Menikoff said. OHRP provides leadership in the

Dimitris Voliotis, Vice President, Nexavar Clinical Development, Bayer HealthCare Pharmaceuticals, said: Nexavar has proven efficacy in liver cancer and kidney cancer and we are committed to researching Nexavar

Under this agreement, AstraZeneca and Merck will work together to evaluate co-administration of the compounds in a Phase I clinical trial for the treatment of solid cancer tumors.

Innovative Spinal is engaged in the development of spinal products. The company develops fixation systems and motion preservation products used in the treatment of spinal disorders. It is

Rigel Pharmaceuticals has announced that its oral Syk inhibitor, R788, is being evaluated in a Phase 2 clinical trial funded, designed and implemented by the National Cancer Institute

GE Healthcare plans to set up a new breast cancer team at QSTP in Doha, Qatar. Based at GE’s Advanced Technology & Research Centre in QSTP in Doha,

An initial order of $90 million of vaccine has been placed, with the potential for additional orders. This project has been funded in whole or in part with

The study, which is intended to be used to support a regulatory filing in the US, includes more than 900 patients aged 51 to 80 with a medical